Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A | P08908 | 7/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.59 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.59 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.59 |
| ▸ | RECQL | P46063 | 1/20 | 0.54 |
| ▸ | HTR7 | P34969 | 4/20 | 0.53 |
| ▸ | PDE4B | Q07343 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | DRD2 | P14416 | 1/20 | 0.52 |
| ▸ | DRD4 | P21917 | 1/20 | 0.52 |
| ▸ | DRD3 | P35462 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8442719 | 0.91 | GAA (0.61) | HTR1AALDH1A1KDM4ECYP1A2CYP3A4 | |
| SCHEMBL8441795 | 0.83 | HTR1A (0.55) | HTR1AALDH1A1KDM4ECYP1A2CYP3A4 | |
| SCHEMBL8443512 | 0.83 | HTR1A (0.64) | HTR1AALDH1A1KDM4ECYP1A2CYP3A4 | |
| SCHEMBL8444594 | 0.83 | HTR1A (0.77) | HTR1AALDH1A1KDM4ECYP1A2CYP3A4 | |
| SCHEMBL8943611 | 0.81 | HTR1A (0.59) | HTR1AALDH1A1KDM4ECYP1A2CYP3A4 | |
| SCHEMBL8943598 | 0.81 | HTR1A (0.59) | HTR1AALDH1A1KDM4ECYP1A2CYP3A4 | |
| SCHEMBL11113037 | 0.80 | HTR1A (0.60) | HTR1AALDH1A1KDM4ECYP1A2CYP3A4 | |
| SCHEMBL8442569 | 0.80 | HTR1A (0.55) | HTR1AALDH1A1KDM4ECYP1A2CYP3A4 | |
| SCHEMBL8442467 | 0.79 | HTR1A (0.78) | HTR1AALDH1A1KDM4ECYP1A2CYP3A4 | |
| SCHEMBL8442534 | 0.78 | HTR1A (0.80) | HTR1AALDH1A1KDM4ECYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0395312-B1 | Piperazine derivatives | WYETH JOHN & BROTHER LTD (GB) | 1999-05-12 | — | — | EP | claimed |
| EP-0395312-A2 | Piperazine derivatives | JOHN WYETH & BROTHER LIMITED (GB) | 1990-10-31 | — | — | EP | claimed |
| EP-0395312-B1 | Piperazine derivatives | WYETH JOHN & BROTHER LTD (GB) | 1999-05-12 | — | — | EP | disclosed |
| US-5541326-A | PHARMACEUTICAL COMPOSITION USED TO TREAT CENTRAL NERVOUS SYSTEM DISORDERS | JOHN WYETH & BROTHER, LIMITED (GB) | 1996-07-30 | — | — | US | disclosed |
| US-5420278-A | ω-(4-aryl or heteroarylpiperazine-1-yl)-2-aryl or aralkyl-propanoic or butanoic acids | JOHN WYETH & BROTHER, LIMITED (GB) | 1995-05-30 | — | — | US | disclosed |
| US-5382583-A | Hydroxytryptamine antagonists | JOHN WYETH & BROTHER, LIMITED (GB) | 1995-01-17 | — | — | US | disclosed |
| US-5364849-A | Treatment of anxiety | JOHN WYETH & BROTHER, LIMITED (GB) | 1994-11-15 | — | — | US | disclosed |
| US-5340812-A | Antiserotonin. anxiolytic agents | JOHN WYETH & BROTHER, LIMITED (GB) | 1994-08-23 | — | — | US | disclosed |
| EP-0395312-A2 | Piperazine derivatives | JOHN WYETH & BROTHER LIMITED (GB) | 1990-10-31 | — | — | EP | disclosed |